Goldman Sachs OTC Derivative Risk Disclosure Document

Goldman Sachs OTC Derivative Risk Disclosure Document The passage is a standard risk disclaimer for OTC derivative transactions with Goldman Sachs affiliates. It contains no specific allegations, transactions, dates, or individuals that suggest actionable investigative leads. It merely outlines generic credit, pricing, and termination risks, offering no novel or controversial information. Key insights: Highlights that OTC derivatives with Goldman Sachs cannot be assigned without consent.; Notes counterparty credit risk and regulatory differences among Goldman affiliates.; Mentions pricing may not be best available and could be influenced by Goldman actions.